• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良苓桂术甘汤联合短期极低热量饮食对糖耐量受损肥胖患者心血管危险因素的保护作用。

Protective effects of modified linggui zhugan decoction combined with short-term very low calorie diets on cardiovascular risk factors in obese patients with impaired glucose tolerance.

机构信息

Traditional Chinese Medicine Department, First Affiliated Hospital of Sun Yat-Sen University, Guang-zhou 510080, China.

出版信息

J Tradit Chin Med. 2012 Jun;32(2):193-8. doi: 10.1016/s0254-6272(13)60010-2.

DOI:10.1016/s0254-6272(13)60010-2
PMID:22876442
Abstract

OBJECTIVE

To observe the protective effects of modified Linggui Zhugan decoction combined with short-term very low calorie diets (VLCDs) on cardiovascular risk factors in obese patients with impaired glucose tolerance (IGT).

METHODS

Eighty-five obese patients with IGT of spleen hypofunction and dampness accumulation type were randomly divided into treated group (n=45)and control group (n=40). The treated group was given Linggui Zhugan decoction combined short-term VLCDs. The control group was given basic weight-reduction treatment. The total course was 6 months. Changes of fasting plasma glucose (FPG), 2-hour postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), lipid metabolism, blood pressure, body mass index (BMI) and waist circumference (WC) were observed, and the outcomes were reviewed after the treatment.

RESULTS

Compared with the control group, the levels of FPG, 2 hPG, HbA1c, FINS, HOMA-IR decreased significantly (P < 0.05), and the indexes of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), systolic blood pressure (SBP), diastolic blood pressure (DBP), BMI and WC were improved significantly (P < 0.05) in the treated group. The transformation rate of normal glucose tolerance (NGT) was higher in treatment group than control group (P < 0.01). No severe adverse reaction was found in the therapeutic course.

CONCLUSION

The modified Linggui Zhugan decoction combined with short-term VLCDs has good protective effects on cardiovascular risk factors as a treatment intervention for IGT with obesity, as it could improve glycometabolism, significantly decrease the levels of blood pressure, blood lipids, BMI, WC and effectively cut-off and reverse the development of diabetes mellitus.

摘要

目的

观察加味苓桂术甘汤联合短期极低热量饮食(VLCD)对糖调节受损(IGT)肥胖患者心血管危险因素的保护作用。

方法

将 85 例脾肾阳虚、痰湿内盛型肥胖 IGT 患者随机分为治疗组(n=45)和对照组(n=40)。治疗组给予苓桂术甘汤联合短期 VLCD。对照组给予基础减肥治疗。总疗程 6 个月。观察空腹血糖(FPG)、餐后 2 小时血糖(2hPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、脂代谢、血压、体重指数(BMI)和腰围(WC)的变化,治疗后评价疗效。

结果

与对照组比较,治疗组 FPG、2hPG、HbA1c、FINS、HOMA-IR 水平明显降低(P<0.05),TC、TG、LDL、SBP、DBP、BMI、WC 等指标明显改善(P<0.05)。治疗组正常糖耐量(NGT)转化率高于对照组(P<0.01)。治疗过程中未发现严重不良反应。

结论

加味苓桂术甘汤联合短期 VLCD 对肥胖 IGT 患者的心血管危险因素具有良好的保护作用,可改善糖代谢,显著降低血压、血脂、BMI、WC 水平,有效阻断和逆转糖尿病的发生发展。

相似文献

1
Protective effects of modified linggui zhugan decoction combined with short-term very low calorie diets on cardiovascular risk factors in obese patients with impaired glucose tolerance.改良苓桂术甘汤联合短期极低热量饮食对糖耐量受损肥胖患者心血管危险因素的保护作用。
J Tradit Chin Med. 2012 Jun;32(2):193-8. doi: 10.1016/s0254-6272(13)60010-2.
2
Effects of the modified linggui zhugan decoction (see text) combined with short-term very low calorie diets on glycemic control in newly diagnosed type 2 diabetics.加味苓桂术甘汤(见正文)联合短期极低热量饮食对新诊断2型糖尿病患者血糖控制的影响。
J Tradit Chin Med. 2011 Sep;31(3):185-8. doi: 10.1016/s0254-6272(11)60038-1.
3
Long-term clinical effect of Tangyiping Granules () on patients with impaired glucose tolerance.糖胰平颗粒治疗糖耐量减低患者的长期临床疗效
Chin J Integr Med. 2016 Sep;22(9):653-9. doi: 10.1007/s11655-016-2512-3. Epub 2016 Sep 11.
4
[Effects of linggui zhugan decoction combined calorie restriction on the insulin resistance of model rats and mechanisms research].苓桂术甘汤联合热量限制对模型大鼠胰岛素抵抗的影响及机制研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Mar;33(3):356-60.
5
Effect of Tang No.1 granule (1) in treating patients with impaired glucose tolerance.糖1号颗粒(1)对糖耐量受损患者的治疗作用。
Chin J Integr Med. 2008 Dec;14(4):298-302. doi: 10.1007/s11655-008-0298-7. Epub 2008 Dec 12.
6
[BO's abdominal acupuncture for obese type-2 diabetes mellitus].[腹针治疗肥胖型2型糖尿病]
Zhongguo Zhen Jiu. 2015 Apr;35(4):330-4.
7
[Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].[腹腔镜袖状胃切除术对病态肥胖患者胰岛素分泌模式的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jan 25;21(1):61-67.
8
[Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].[东莞市超重或肥胖青少年学生糖调节受损及代谢综合征情况]
Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jun;43(6):495-500.
9
[Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].社区人群血清脂肪细胞脂肪酸结合蛋白与2型糖尿病的关系
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar;31(3):508-11.
10
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.多沙唑嗪与阿卡波糖对改善糖耐量受损患者代谢控制的协同作用。
Clin Drug Investig. 2006;26(9):529-39. doi: 10.2165/00044011-200626090-00006.

引用本文的文献

1
The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms.中药治疗慢性心力衰竭及其主要生物活性成分和作用机制。
Acta Pharm Sin B. 2023 May;13(5):1919-1955. doi: 10.1016/j.apsb.2023.02.005. Epub 2023 Feb 11.
2
Effectiveness and safety of Linggui Zhugan decoction for the treatment of premature contraction in patients with coronary heart disease: A systematic review and meta-analysis.苓桂术甘汤治疗冠心病早搏的有效性和安全性:一项系统评价与Meta分析
Front Cardiovasc Med. 2022 Nov 3;9:1002378. doi: 10.3389/fcvm.2022.1002378. eCollection 2022.
3
Efficacy and safety of traditional chinese medicine treatment for overweight and obese individuals: A systematic review and meta-analysis.
中药治疗超重和肥胖个体的疗效与安全性:一项系统评价和荟萃分析。
Front Pharmacol. 2022 Oct 5;13:964495. doi: 10.3389/fphar.2022.964495. eCollection 2022.
4
Clinical Evidence and Potential Mechanisms of Complementary Treatment of Formula for the Management of Serum Lipids and Obesity.用于管理血脂和肥胖的配方辅助治疗的临床证据及潜在机制
Evid Based Complement Alternat Med. 2022 May 9;2022:7714034. doi: 10.1155/2022/7714034. eCollection 2022.
5
Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis.逆转前期糖尿病的干预措施:系统评价和荟萃分析。
Am J Prev Med. 2022 Apr;62(4):614-625. doi: 10.1016/j.amepre.2021.10.020. Epub 2022 Feb 10.
6
Verification of the Efficacy and Safety of Qi-Replenishing Chinese Medicine in Treating Prediabetes: A Meta-Analysis and Literature Review.益气中药治疗糖尿病前期疗效与安全性的验证:一项Meta分析与文献综述
Evid Based Complement Alternat Med. 2020 Nov 10;2020:7676281. doi: 10.1155/2020/7676281. eCollection 2020.
7
Efficiency and Safety of Chinese Herbal Medicine in the Treatment of Prediabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.中药治疗糖尿病前期的有效性和安全性:随机对照试验的系统评价和Meta分析
Evid Based Complement Alternat Med. 2020 Oct 14;2020:3628036. doi: 10.1155/2020/3628036. eCollection 2020.
8
Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017.用于治疗肥胖症的草药医学:2007年至2017年科学证据综述
Evid Based Complement Alternat Med. 2017;2017:8943059. doi: 10.1155/2017/8943059. Epub 2017 Sep 25.
9
Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome.加味苓桂术甘汤联合饮食限制及运动可改善代谢综合征大鼠模型的高血糖、高血脂及高血压。
BMC Complement Altern Med. 2017 Feb 28;17(1):132. doi: 10.1186/s12906-017-1557-y.
10
Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS.迈向中国农村糖尿病的综合与可持续防控:eCROPS 研究的背景与方案。
BMC Endocr Disord. 2013 Aug 7;13:28. doi: 10.1186/1472-6823-13-28.